Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00145Z
Serotype : AAV Serotype 1 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00145Z |
| Description | AAV serotype 1 particles contain GFP under a muscle cell specific promoter (tMCK). |
| Serotype | AAV Serotype 1 |
| Reporter | GFP |
| Applications |
1. Determination of optimal MOI (multiplicity of infection), administration methods etc. 2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue. 3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery. |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
Adeno-associated viruses are non-enveloped, helper-dependent parvoviruses with an icosahedral capsid structure of approximately 25 nm in diameter. AAV encapsidates a genome of approximately 4.7 kb flanked by approximately 145 bp of inverted terminal repeats (ITRs) at the 5′ and 3′ ends. The wild-type AAV (wtAAV) genome is a linear single-stranded DNA consisting of two open reading frames (ORFs). The AAV ORFs encode four replication proteins (Rep) and three capsid proteins (Cap/VP) as well as an assembly activation protein (AAP). In addition, wtAAV requires co-infection with adenovirus or herpes simplex virus (HSV) for successful replication and production of viable AAV particles.
Three advances have facilitated the use of AAV as a recombinant vector for gene transfer applications: (a) the ability to pseudotype AAV vectors by using AAV capsids of either natural or synthetic origin; (b) the cloning and characterization of adenoviral helper genes that are minimally required to produce infectious AAV particles; and (c) the understanding that the ITRs are the only cis-acting molecular features required for successful transgene packaging within the AAV capsid. These simplified components are now used to make recombinant AAV (rAAV) vectors, packaging a variety of promoter elements and transgene cassettes for different gene transfer applications.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The quality control measures for the AAV1-tMCK-GFP are evident, as I have consistently received high-titer preparations. Additionally, Creative Biogene was reliable in terms of quick and secure delivery, which ensured our projects stayed on schedule.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.